Drug Shortage Report for TARO-PEMETREXED
Report ID | 92828 |
Drug Identification Number | 02429195 |
Brand name | TARO-PEMETREXED |
Common or Proper name | TARO-PEMETREXED |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | PEMETREXED |
Strength(s) | 100MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 4 ml |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-08-28 |
Estimated end date | 2020-03-06 |
Actual end date | 2020-02-27 |
Shortage status | Resolved |
Updated date | 2020-03-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2020-03-07 | French | Compare |
v14 | 2020-03-07 | English | Compare |
v13 | 2020-02-11 | French | Compare |
v12 | 2020-02-11 | English | Compare |
v11 | 2020-01-28 | French | Compare |
v10 | 2020-01-28 | English | Compare |
v9 | 2020-01-04 | French | Compare |
v8 | 2020-01-04 | English | Compare |
v7 | 2020-01-04 | English | Compare |
v6 | 2019-10-04 | French | Compare |
v5 | 2019-10-04 | English | Compare |
v4 | 2019-09-23 | French | Compare |
v3 | 2019-09-23 | English | Compare |
v2 | 2019-09-03 | French | Compare |
v1 | 2019-09-03 | English | Compare |
Showing 1 to 15 of 15